Fidelity Investments’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $333M | Buy |
|
|||||
|
2025
Q2 | $237M | Buy |
|
|||||
|
2025
Q1 | $121M | Sell |
|
|||||
|
2024
Q4 | $194M | Sell |
|
|||||
|
2024
Q3 | $242M | Buy |
|
|||||
|
2024
Q2 | $144M | Buy |
|
|||||
|
2024
Q1 | $175M | Buy |
|
|||||
|
2023
Q4 | $13.6M | Sell |
|
|||||
|
2023
Q3 | $12.1M | Buy |
|
|||||
|
2023
Q2 | $19.3M | Buy |
|
|||||
|
2023
Q1 | $19.8M | Sell |
|
|||||
|
2022
Q4 | $21.1M | Buy |
|
|||||
|
2022
Q3 | $7.09M | Sell |
|
|||||
|
2022
Q2 | $6.83M | Sell |
|
|||||
|
2022
Q1 | $81.4M | Sell |
|
|||||
|
2021
Q4 | $149M | Sell |
|
|||||
|
2021
Q3 | $138M | Buy |
|
|||||
|
2021
Q2 | $106M | Sell |
|
|||||
|
2021
Q1 | $91.4M | Sell |
|
|||||
|
2020
Q4 | $151M | Buy |
|
|||||
|
2020
Q3 | $73.1M | Buy |
|